|
High $0.38 |
Low $0.38 |
Trades 2 |
Turnover $1,293 |
Volume 3,448 |
| 30 June 2023 at 10:43am | ||||
|
Market Cap (14-Nov) $16,699,372 (1,586th) |
Close (30-Jun) $0.375 |
Volume (30-Jun) 3,448 |
Shortsold (3-Jul) 15,198 (0.01%) (627th) |
|
52w High $0.345 |
52w Low $0.087 |
P/E - |
EPS -0.01 |
Notice of Annual General Meeting/Proxy Form
AGN released this announcement to the ASX on 15 October 2021, 11:08. The announcement is not marked as price sensitive, and is 20 page(s) in length and 556.91kb in size.
You can view all announcements from AGN and see how they appear on a price chart on the announcements page.
At the date of this announcement, AGN was 0.000% short sold according to ASIC data. It was ranked the 653rd most shorted stock on the ASX. It is now ranked as the 627th most shorted stock on the ASX with 0.012% of total shares short sold as of the latest reported data (03 July 2026).
| Other Recent Announcements from AGN | |
|---|---|
| ARG-007 Protects Brain Cells in Moderate TBI Model | 22 June 2023, 8:19 |
| Becoming a substantial holder | 20 June 2023, 8:21 |
| Becoming a substantial holder | 13 June 2023, 17:34 |
| Notice of Annual General Meeting/Proxy Form | 15 October 2021, 11:08 |
| Application for quotation of securities - AGN | 14 October 2021, 12:31 |
| Release of Restricted Securities from Escrow | 4 October 2021, 8:15 |
| Argenica Partners With Linear For Phase 1 Clinical Trial | 30 September 2021, 9:52 |
If you were already registered, log in here.